Related Experiment Video
Updated: Jul 20, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
The human myeloperoxidase gene is regulated by LXR and PPARalpha ligands
Wanda F Reynolds1, Alan P Kumar, F Javier Piedrafita
1Sidney Kimmel Cancer Center, San Diego, CA 92121, USA. wreynolds@skcc.org
Abstract:
Myeloperoxidase (MPO) is an oxidant-generating enzyme expressed in macrophages and implicated in atherosclerosis and cholesterol homeostasis. LXRalpha and PPARalpha regulate genes involved in cholesterol metabolism and the inflammatory response in macrophages. Here, we examine the effect of LXR and PPARalpha ligands on MPO expression. LXR and PPARalpha, as heterodimers with RXR, are shown to bind overlapping sites in an Alu receptor response element (AluRRE) in the MPO promoter. The LXR ligand T0901317 suppresses MPO mRNA expression in primary human macrophages, and in bone marrow cells and macrophages from huMPO transgenic mice. The PPARalpha ligand GW9578 downregulates MPO expression in GMCSF-macrophages, while upregulating in MCSF-macrophages. In contrast, the mouse MPO gene, which lacks the primate-specific AluRRE, is not regulated by LXR or PPARalpha ligands. These findings identify human MPO as a novel LXR and PPARalpha target gene, consistent with the role of these receptors in regulation of proinflammatory genes in macrophages.
Insights
Liver X Receptor (LXR) and Peroxisome proliferator-activated receptor alpha (PPARα) ligands regulate human myeloperoxidase (MPO) expression. These nuclear receptors target the MPO gene, impacting inflammatory processes in macrophages.
Area of Science:
- Molecular biology
- Cell biology
- Biochemistry
Background:
- Myeloperoxidase (MPO) is an enzyme in macrophages linked to atherosclerosis and cholesterol metabolism.
- Liver X Receptor alpha (LXRα) and Peroxisome proliferator-activated receptor alpha (PPARα) are key regulators of cholesterol and inflammation in macrophages.
Purpose of the Study:
- To investigate the impact of LXR and PPARα ligands on human MPO gene expression.
- To determine the regulatory mechanisms of MPO by these nuclear receptors.
Main Methods:
- Analysis of MPO promoter activity using Alu receptor response elements (AluRRE).
- Treatment of primary human macrophages and transgenic mouse models with LXR and PPARα ligands.
- Quantitative assessment of MPO mRNA expression.
Main Results:
- LXR and PPARα, as heterodimers with RXR, bind to overlapping sites in the MPO promoter's AluRRE.
- LXR ligand T0901317 suppressed MPO mRNA in human and mouse macrophages.
- PPARα ligand GW9578 differentially regulated MPO expression based on macrophage type (GM-CSF vs. M-CSF).
- The mouse MPO gene, lacking AluRRE, was not affected by LXR or PPARα ligands.
Conclusions:
- Human MPO is identified as a novel target gene for LXR and PPARα.
- These findings highlight the role of LXR and PPARα in controlling proinflammatory gene expression in macrophages.
- The primate-specific AluRRE is crucial for MPO regulation by LXR and PPARα.
Related Concept Videos
Master Transcription Regulators
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Cell Specific Gene Expression
Peroxisomes
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
